President – Prof Finbarr Martin (UK)
|Name||MARTIN, Finbarr Callaghan|
|Degrees||University of London: BSc Physiology (1970) MB BS (1974), |
MSc Biochemistry (1982)
Research MD – pathphysioplogy of muscle wasting conditions (1984)
|Fellowships||Royal College of Physicians of London (1990) |
Royal College of Speeech & Language Therapy (Honorary, 1996)
- Finbarr Martin has 30 years’ experience as a full-time NHS consultant at Guys and St Thomas’ NHS Foundation Trust in London (1984 to 2014). During this period, he worked in acute geriatrics and general internal medicine and in a variety of community services for older people. He now now does part-time clinical work in Geriatric Medicine, in specialist multidisciplinary community teams and in care homes medicine.
- His department have developed and evaluated several CGA based novel services for older people in acute and post acute care in medicine and surgery. He developed the prototype “supported discharge team” in 1988, and continues to work with this expanded multidisciplinary team of 30 staff. He developed a specialist multidisciplinary team to support 1500 residents of care homes.
- His research is into the geriatric syndromes of falls, frailty and delirium and new service models to improve care for these patients in non-specialist geriatric medicine settings such as surgery. He was awarded a personal in King’s College London in 2011.
- He led the creation of the England Department of Health falls and fractures toolkit, and is now clinical lead for the national Falls and Fragility Fractures Audit programme, which incorporates the National Hip Fracture Database.
- He has had several national and international leadership roles and he has the experience, vision, knowledge and commitment to help the EUGMS continue its great progress.
- Consultant Geriatrician at Guy’s & St Thomas’ NHS Foundation Trust, London (part-time)
- Professor of Medical Gerontology, King’s College London (honorary)
- Clinical Lead for National Falls and Fragility Fractures Audit Programme (2012-)
- Non-executive director, NICE (National Institute of Health and Care Excellence (2013-)
Previous professional leadership roles
- President, British Geriatrics Society (2010-12)
- Department of Health: National Clinical Director for Older People (acting) 2008-2010
- Royal College of Physicians of London - member of Council (2010-12)
- Co-chair, National Hip Fracture Database (2007-2012)
- EUGMS: execuive board member as president’s adviser - 2013-15
- EUGMS: board member for UK - 2010-12
- EUGMS: Chair, Care Homes Special Interest Group - 2013-15
- EUGMS working party on Sarcopenia –member and co-author - 2009-10
- Fragility Fratures Network (Global): executive board member - 2011-16
- Co-author BGS-AGS Clinical guidelines on falls - 2001, 2009
- Invited lecturer at national geriatric medicine/gerontology congresses: Spain, Australia, Ireland, UK, New Zealand, Taiwan, Sweden - 2005-9
- ProFANE Workstream 3 (EU funded European falls research network)
Research and Development –current activities
- Evaluation of using CGA in hospital medicine and surgery services
- Evaluating how healthcare can be best provided for care home residents
- RCT of falls prevention interventions
- Health outcomes and service use associated with malnutrition in various service settings
- Developing frailty assessment as a practical tool in service delivery for older people
- The impact of surgical interventions on sarcopenia
Research and Development -advisory/leadership roles
- Chair of Trial Steering Group for 3 National Institute of Health Research funded studies (i) Prevention of delirium in care homes (PitSTOP)
(ii) Prevention of delirium in hospitals (POD-HELP)
(iii) Better Health in Residents in Care Homes
- Advisory Group Of Experts, UK Medical Research Council - Later Life & Well Being research programme: 2011-2014
- The Irish Longitudinal Study on Ageing TILDA, Scientific Advisory Board, 2012-
- Academic Lead for Frailty theme, NW London Collaboration for Leadership in Applied Health Research and Care (CLAHRC)
Education, teaching and training roles
- King’s College London: undergraduate MB BS, Gerontology BSc, Law and Ethics BSc,
- King’s College London MSc Gerontology - Lecturer, Examiner, Dissertation supervisor,
- External Examiner for Medicine at Edinburgh and Brighton and Sussex Medical Schools
- Royal College of Physicians MRCP PACES Examiner 2002-13
Vision for the EUGMS
The EUGMs is only 15 years old, still a teenager! It has made great progress. The most significant achievement is the ever improving annual Congress, but it is clear that it has also had impact on EU policy (medications), international scientific thinking (eg. sarcopenia) and international education (eg. TNT Geriatrics). EUGMS is now the European voice for the specialty. It needs to be heard more often, in more places, with loud and clear messages.
But we have several challenges for the next 5 years:
- To become financially independent and sustainable, by securing new sources of funds or its activities, reducing its reliance on the Congress and industry support.
- To support the development of Geriatric Medicine Services across Europe in an age of austerity. We can help by production of scientific and clinical guidelines, reports and position papers concerning the older patient. We can aim to develop quality standards in Geriatric Medicine, for EU wide implementation. Better care for older citizens usually means more efficient health care services. This is an important lesson to disseminate.
- We already support improving standards of education and training and must continue to work with colleagues in UEMS. We are primarily an organisation of doctors, but we can also develop influence and common purpose with other health professionals.
- EUGMS can support networking across European geriatricians, especially young clinicians and scientists who will be the future leaders. We can be leaders in the creation of a European Institute of Ageing, fostering the development of research and clinician scientists but also to the public, other health care professionals, and the scientific community.
- We must represent the interests of older patients and geriatric medicine at the EU: to be influential, we need to build alliances with organisations representing patients, older citizens, and policy makers.